AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 137 filers reported holding AVIDITY BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $360,649 | -33.0% | 56,528 | +16.5% | 0.00% | -50.0% |
| Q2 2023 | $538,242 | -38.0% | 48,534 | -14.2% | 0.00% | -33.3% |
| Q1 2023 | $868,457 | +1.8% | 56,577 | +47.2% | 0.00% | 0.0% |
| Q4 2022 | $852,740 | +44.3% | 38,429 | +6.3% | 0.00% | +50.0% |
| Q3 2022 | $591,000 | +7.8% | 36,168 | -4.0% | 0.00% | +100.0% |
| Q2 2022 | $548,000 | -24.3% | 37,684 | -3.9% | 0.00% | -50.0% |
| Q1 2022 | $724,000 | -22.3% | 39,200 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $932,000 | -3.4% | 39,200 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $965,000 | -0.4% | 39,200 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $969,000 | +88.2% | 39,200 | +66.1% | 0.00% | +100.0% |
| Q1 2021 | $515,000 | -14.5% | 23,600 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $602,000 | – | 23,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 907,567 | $22,353,000 | 19.68% |
| 5AM Venture Management, LLC | 555,555 | $13,683,000 | 2.78% |
| Octagon Capital Advisors LP | 446,641 | $11,001,000 | 2.71% |
| EcoR1 Capital, LLC | 2,759,505 | $67,967,000 | 2.36% |
| Cormorant Asset Management, LP | 2,162,115 | $53,253,000 | 2.16% |
| Asymmetry Capital Management, L.P. | 126,116 | $3,106,000 | 1.87% |
| RTW INVESTMENTS, LP | 4,795,000 | $118,101,000 | 1.78% |
| Aaron Wealth Advisors LLC | 229,595 | $5,654,000 | 1.59% |
| Altium Capital Management LP | 225,000 | $5,542,000 | 1.45% |
| Boxer Capital, LLC | 1,121,327 | $27,618,000 | 0.96% |